Organometallics
Article
(C6D6): δ 87.7 (Pyr), 82.8 (Cp* quat), 74.2 (Pyr), 36.2 (CH2), 30.6
(CH2), 26.6 (CH2), 25.8 (CH2), 25.7 (br, B-CH), 10.29 (Cp* CH3).
11B NMR (C6D6): δ −5.5 (d, J = 91). IR (ATR): ν 2910, 2880, 2840,
2315, 2280, 2245, 1455, 1383, 1380, 1200, 1190, 1025, 915, 910, 820,
690 cm−1. Anal. Calcd for C22H34NBFe: C, 69.64; H, 9.04; N, 3.69.
Found: C, 68.92; H, 9.22; N, 3.58.
Preparation of PMAF-BCl3 (8). BCl3 (0.97 mL, 1.0 M solution in
CH2Cl2) was added to a stirred solution of PMAF (250 mg, 0.97
mmol) in CH2Cl2 (3 mL). After 30 min, the crude product was
precipitated by the dropwise addition of a large excess of hexane to the
stirring solution, and then the solution was stored at −35 °C to ensure
complete precipitation. The supernatant was then decanted and the
orange product dried in vacuo, and this product was shown by NMR
to be pure enough for use. Yield: 360 mg (0.97 mmol, 99%).
Recrystallization of the product from a concentrated CH2Cl2 solution
layered with hexane at −35 °C yielded analytically pure material and
crystals suitable for single-crystal X-ray diffraction.
BCH). 11B{1H} NMR (CD2Cl2): δ −0.7 (br s, boronium), −17.7
(BArF anion).
General Protocol for Formation and Observation of
Borenium Ions 3 and 4. In a typical procedure, solutions of 1 or
2 (20−25 mg) and the Tr+ salt (1 equiv) were mixed in CH2Cl2 or
CD2Cl2 (total volume 1 mL) under nitrogen at −35 °C for 15 min
before transfer to an NMR tube, which was then sealed and monitored
by 11B NMR (and 19F NMR) at room temperature. On mixing the
solutions turned immediately from orange to dark red. Solutions for
UV−vis spectroscopy were prepared in a similar way.
Formation of 4 from 3. A solution of 1 (20.2 mg, 0.0745 mmol)
and [CPh3]+[B(C6F5)4]− (70 mg, 0.0758 mmol) were mixed in
CD2Cl2 (total volume 1.5 mL) under nitrogen at −35 °C for 15 min
before transfer to an NMR tube, which was then sealed with a rubber
septum. 11B NMR spectroscopy confirmed the formation of 3, as
indicated by a new peak at 40 ppm. 1,5-Cyclooctadiene (9.20 μL,
0.0750 mmol) was then added by syringe into the NMR tube and the
reaction monitored by 1H and 11B NMR spectroscopy. Complete
conversion of 3 to 4 was observed after 24 h by the formation of a new
11B peak at 68 ppm.
1H NMR (CD2Cl2): δ 5.64 (s, 2H, Pyr), 4.70 (s, 2H, Pyr), 1.93 (s,
15H, Cp*). 13C{1H} NMR (CD2Cl2): δ 85.78 (Pyr), 85.29 (Cp*
quat), 78.6 (Pyr), 10.9 (Cp* CH3). 11B NMR (CD2Cl2): 5.3 (s). IR
(ATR): ν 3130, 3100, 2990, 2905, 1490, 1460, 1425, 1390, 1202, 1060,
1150, 1145, 815, 795, 766, 715, 695 cm−1. Anal. Calcd for
C14H19NBCl3Fe: C, 44.88; H, 5.11; N, 3.74. Found: C, 45.05; H,
5.09; N, 3.61.
Preparation of [PMAF-BCl2]+[AlCl4]− (9). PMAF-BCl3 (60 mg,
0.16 mmol) and AlCl3 (21 mg, 0.16 mmol) were mixed in CH2Cl2 (3
mL) and stirred until all the AlCl3 dissolved to give a dark red solution.
Excess hexane (10 mL) was layered on top of the solution, which was
stored at −35 °C overnight. The supernatant was then decanted,
leaving dark red crystals (81 mg, 99% yield), which were dried in
vacuo. Single crystals suitable for X-ray diffraction were grown by the
same method.
Preparation of [(PMAF)2BH2]+[B(C6F5)4]− (6). 1 (51 mg, 0.19
mmol) and PMAF (50 mg, 0.19 mmol) were dissolved in CH2Cl2 (1
mL) and precooled to −35 °C. A solution of [CPh3]+[B(C6F5)4]−
(175 mg, 0.189 mmol) in CH2Cl2 (1 mL), also precooled to −35 °C,
was added and the solution stored at −35 °C for 20 min before stirring
at room temperature for 15 min. Hexane (10 mL) was added dropwise
until formation of a red precipitate was complete. The colorless
solution was then decanted, and the precipitate was dried in vacuo.
The red-orange solid was then redissolved in CH2Cl2 (1 mL), filtered,
and layered with excess hexane (10 mL). After 2 days at room
temperature, analytically pure red-orange crystals (146 mg, 62% yield)
suitable for single-crystal X-ray diffraction formed in a colorless
solution.
1H NMR (CD2Cl2): δ 6.03 (s, 2H, Pyr), 5.70 (s, 2H, Pyr), 1.87 (s,
15H, Cp*). 13C{1H} NMR (CD2Cl2): δ 90.1 (Cp* quat), 86.13 (Pyr),
86.06 (Pyr), 10.5 (Cp* CH3). 11B NMR (CD2Cl2): δ 39 (s). IR
(ATR): ν 3120−2900 (br), 1640, 1570, 1540, 1520, 1385, 1340, 1260,
1185, 1080, 1040, 1010, 980, 815, 795, 670 cm−1. Anal. Calcd for
C14H19NAlBCl6Fe: C, 33.11; H, 3.77; N, 2.76. Found: C, 32.13; H,
3.59; N, 2.17.
Lewis Acidity Measurements. Solutions of borenium cations 3,
4, and 9 were prepared as described above in CH2Cl2 or CD2Cl2 and
mixed with 1 equiv of Et3PO (in the case of cation 4 excess Et3PO (2−
3 equiv) was necessary to give a resolvable 31P NMR signal for the
adduct). The solution was placed in an NMR tube containing an insert
containing a solution of Et3PO in CD2Cl2, the tube was sealed, and
31P{1H} and 11B{1H} NMR spectra were obtained. Δδ values were
1H NMR (CD2Cl2): δ 4.96 (s, 2H, Pyr), 4.47 (s, 2H, Pyr), 2.55 (v
br, w1/2h = 235 Hz, −BH2−), 1.90 (s, 15H, Cp*). 13C{1H} NMR
(CD2Cl2): δ (cation only) 86.75 (Pyr), 84.95 (Cp* quat), 77.44 (Pyr),
10.37 (Cp* CH3). 11B{1H} NMR (CD2Cl2): −7.6 (br s, −BH2−),
−17.7 (s, BArF). IR (KBr disk): ν 2978, 2962, 2916, 2866, 2461, 2429,
1644, 1515, 1464, 1378, 1276, 1134, 1086, 1059, 979, 775, 756, 684,
661, 480 cm−1. Anal. Calcd for C52H40N2B2F20Fe2·CH2Cl2: C, 49.27;
H, 3.28; N, 2.17. Found: C, 49.12; H, 3.11; N, 2.13 (in agreement with
the X-ray crystal structure, which shows one molecule of CH2Cl2 per
ion pair).
obtained by comparing the 31P chemical shift of the adduct formed to
that of Et3PO in the insert solution. Attempts to perform competition
experiments in which in situ generated 3 and 9 were mixed with
equimolar B(C6F5)3 and Et3PO gave several additional unidentified
impurity peaks by 31P NMR. Therefore, a competition experiment
among 3, B(C6F5)3, and Et3PO was performed by mixing premade
[PMAF-BH2-OPEt3]+[B(C6F5)4]− (3-OPEt3, 1 equiv; for full NMR
characterization see the Supporting Information) and B(C6F5)3 (1
equiv) and monitoring the 31P{1H} and 11B{1H} NMR spectra. Under
these conditions the solutions were stable for 1−2 h and one minor
impurity peak (∼8% of total integration) was observed at 96 ppm in
the 31P{1H} NMR spectrum.
Details of X-ray Data Collection, Structure Determination,
and Refinement. In the crystal structure of 2, there are two
independent molecules in the asymmetric unit which differ primarily in
the Fe−N−B−H dihedral angle. The asymmetric unit of 5 contains
two independent molecules. The structure of 6 contains a molecule of
CH2Cl2 per ion pair (in agreement with analysis data), which lies on a
crystallographic inversion center. This molecule showed extreme
disorder and was therefore rendered using the SQUEEZE routine. The
asymmetric unit of 7 contains four independent ion pairs and one
molecule of CH2Cl2. The crystal displayed nonmerohedral twinning
with approximately 5% of the minor component, as the monoclinic β
angle is very close to 90°. In the structure of 9, two independent ion
pairs were found in the asymmetric unit. Both cation/ion pairs lie on a
crystallographic mirror plane and one of the cations showed positional
disorder of the pyrrolyl-BCl2 moiety between two orientations about
Preparation of [(N-methylimidazole)2B(C8H14)]+[B(C6F5)4]−
(7). 2 (20 mg, 0.053 mmol) was dissolved in CH2Cl2 (1 mL) and
the solution precooled to −35 °C. A solution of [CPh3]+[B(C6F5)4]−
(49 mg, 0.053 mmol) in CH2Cl2 (1 mL), also precooled to −35 °C,
was then added to the solution of 2, and the mixture was warmed to
room temperature before transfer to an NMR tube which was sealed
with a rubber septum. 11B NMR showed complete conversion to 4. N-
Methylimidazole (4.4 μL, 0.055 mmol) was added via syringe and the
solution again monitored by11B NMRin addition to peaks at 68 (4)
and −18 ppm (anion) a small peak at around 0 ppm was observed. An
additional portion of N-methylimidazole (4.2 μL, 0.053 mmol) was
then added, leading to complete loss of the peak at 68 ppm and
formation of a peak at −0.8 ppm in the 11B spectrum. Excess hexane
was added to the solution, causing a brown oil to form, which was
isolated by decantation and dried in vacuo. This oil was redissolved in
CH2Cl2 and cooled to −35 °C. Over a period of 2 weeks small
colorless crystals formed which were suitable for single-crystal X-ray
diffraction. Yield: 15 mg (0.016 mmol, 30%).
1H NMR (CD2Cl2): δ 7.86 (s, 2H, Im), 7.15 (s, 2H, Im), 7.03 (s,
2H, Im), 3.85(s, 6H, N-CH3), 1.90 (m, 2H), 1.79 (m, 4H), 1.50 (m,
4H), 1.36 (m, 4H). 13C{1H} NMR (CD2Cl2): δ 135.3 (Im), 122.95
(Im), 122.92 (Im), 35.6 (CH2), 30.2 (N-CH3), 23.4 (CH2), 21.0 (br,
2828
dx.doi.org/10.1021/om500348u | Organometallics 2014, 33, 2820−2830